A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...

AstraZeneca Plc on Monday reported Phase 3 EMERALD-3 trial results showing that its immunotherapy-based STRIDE regimen, when ...

AstraZeneca added to its Imfinzi armamentarium on Monday after the immuno-oncology drug led to improved survival in liver ...

Dr. Jason Chiang and Dr. Kyung Sung of the department of radiological sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3 ...

A three-drug regimen incorporating AstraZeneca's immune checkpoint inhibitors Imfinzi and Imjudo has reduced the risk of ...

Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that ...

Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that ...

Adding an immunotherapy-based regimen to standard treatment may improve outcomes for some patients with liver cancer who are ...

Discover how genetic fatty liver combined with diabetes and obesity significantly increases liver cancer risk, according to a ...

For decades, giant mitochondria-known as megamitochondria-have been recognized in liver biopsies from patients with alcohol-associated liver disease (ALD).

MRI approach also led to fewer false referrals ...

Embolization is a safe, noninvasive treatment option for liver cancer tumors that can’t be removed surgically. You can usually go home on the same day as an embolization procedure, and side effects ...